We are live on ! Find out more
ST

Skorpios Trust Portfolio holdings

AUM $53.2M
1-Year Est. Return 90.96%
This Fund
S&P 500
This Quarter Est. Return
-9.01%
1 Year Est. Return
+90.96%
3 Year Est. Return
+173.58%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$110M
AUM Growth
-$37M
Cap. Flow
-$27.4M
Cap. Flow %
-25.04%
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
1
Closed
–
Avg Time Held
11 quarters
Top 10 Avg Time Held
11 quarters
Top 20 Avg Time Held
11 quarters

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
STOK icon
Stoke Therapeutics
STOK
+$27.4M

Sector Composition

Rank Sector Weight
1 Healthcare 99.85%
2 Miscellaneous 0.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
STOK icon
1
Stoke Therapeutics
STOK
$1.56B
$109M 99.85%
8,906,181
-1,937,500
-18% -$27.4M
2021 Q4
11 quarters
XBI icon
2
State Street SPDR S&P Biotech ETF
XBI
$10B
$167K 0.15%
1,686
– –
2021 Q4
11 quarters

Similar funds

ACM
Aurelius Capital Management New York $55.2M AUM 124.79% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
CCCPV
Castle Creek Capital Partners VI San Diego, California $55.9M AUM 7.91% 1-Year Est. Return
SGA
Siguler Guff Advisers New York $56.1M AUM 46.63% 1-Year Est. Return
NCFG
New Century Financial Group Princeton, New Jersey $56.3M AUM 16.99% 1-Year Est. Return
E
EnerVest Houston, Texas $50.1M AUM 2.25% 1-Year Est. Return
RPM
Ridgemont Partners Management Charlotte, North Carolina $49.7M AUM 26.51% 1-Year Est. Return
ECT
Ebor Charitable Trust Jackson, Wyoming $49.4M AUM 13.04% 1-Year Est. Return

Skorpios Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Skorpios Trust held 2 positions worth $110M, down 25% from $147M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Skorpios Trust withdrew a net $27.4M in Q3 2024, reducing 1 holding. Its largest reduction was Stoke Therapeutics, cutting an estimated $27.4M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, down from 100% a quarter earlier, followed by Miscellaneous.

  • Skorpios Trust's biggest Q3 2024 reduction was Stoke Therapeutics, cutting an estimated $27.4M.
  • Skorpios Trust's ten largest holdings make up 100% of its $110M portfolio in Q3 2024.
  • Skorpios Trust opened 0 new positions and closed 0 in Q3 2024.
  • Skorpios Trust's portfolio value fell 25% quarter-over-quarter to $110M.

Based on Skorpios Trust's 13F filing for Q3 2024, filed 23 Oct 2024.